Do’s And Don’ts: Social Media Tips for Pharmacists
Drug Topics
JULY 20, 2023
Social media marketing is a powerful tool that pharmacists can use.
Drug Topics
JULY 20, 2023
Social media marketing is a powerful tool that pharmacists can use.
PharmaVoice
JULY 20, 2023
Peter Benton, co-CEO of Worldwide Clinical Trials, explains how the rise of the mid-sized pharma company has changed drug R&D.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 20, 2023
The FDA is working quickly to address shortages of the form used in nebulizers.
PhRMA
JULY 20, 2023
Most insured Americans believe insurance should provide affordable access to health care (93%), but only a third (34%) say it does, according to the fourth installment of the Patient Experience Survey (PES). The survey — based on interviews with 5,000 Americans — explores this disconnect, detailing the challenges insured Americans face affording care and how practices by health insurers and middlemen put patient lifelines to access at risk.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 20, 2023
Issues within chain pharmacies have made the profession less attractive for new graduates.
Pharmacy Times
JULY 20, 2023
Managing cost savings can soften the blow of direct and indirect remuneration fee reform that will impact pharmacists during the first half of 2024.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JULY 20, 2023
A smartwatch may be able to replace a sleep diary to evaluate falling asleep and waking times for those with insomnia.
Drug Topics
JULY 20, 2023
Technology can bolster and optimize independent pharmacies’ delivery of clinical services.
Pharmacy Times
JULY 20, 2023
Many living in lower-income rural populations face significant unmet social needs that can bar access to important mental health services.
Drug Topics
JULY 20, 2023
Drug Topics was recently joined by Kevin Smith, PharmD from Prescyptive Health to talk about how the landscape of pharmacy changing, how AI and technology are part of that change, and what can be done to repair a broken system.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 20, 2023
Not only is a combination of in-office visits and telemedicine an effective model of prenatal care, but it can be an alternative to those who face access barriers.
Drug Topics
JULY 20, 2023
Employers must make changes in order to hire and retain high-quality talent.
PharmaVoice
JULY 20, 2023
Efforts to tackle drug pricing, shortages, the speed of FDA approvals and more have been mixed into Congress’ efforts to reauthorize the Pandemic and All Hazards Preparedness Act.
Drug Topics
JULY 20, 2023
Zavegepant joins other CGRP antagonists as an option for individuals experiencing migraine.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
JULY 20, 2023
Genomenon’s acquisition of their contract scientific partner Boston Genetics will help them unlock the potential of genetic knowledge.
Drug Topics
JULY 20, 2023
The world continues to become more automated, but how much responsibility should you give AI within your pharmacy?
STAT
JULY 20, 2023
The tornado that struck parts of North Carolina on Wednesday not only damaged the immediate area, but could soon make it much harder for countless people across the U.S. and around the world to obtain needed medicines the next time they visit a hospital. Among the damaged buildings was a Pfizer plant in Rocky Mountain, N.C. that produces nearly 30% of all sterile injectable medicines that the company sells to U.S. hospitals.
Drug Topics
JULY 20, 2023
Most pharmacies are now utilizing text message programs for their customers. How can they be fully utilized, and what is the next step?
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JULY 20, 2023
After Stanford University president and prominent neuroscientist Marc Tessier-Lavigne announced he would resign following an investigation into his research, the scientific community did what it always does with new results: engage in a robust internal debate, marked by a variety of opinions. For some, the investigation , which found Tessier-Lavigne failed to “decisively and forthrightly” correct past papers that contained data manipulation, was a positive example of scientific acc
Fierce Healthcare
JULY 20, 2023
Senate Health, Education, Labor and Pensions (HELP) Committee Chair Sen. | The influential Democrat's legislation is slated for committee markup next week, but is already being speared by Republicans for its price tag and hospitals for measures requiring site-neutral payments.
STAT
JULY 20, 2023
Private equity firms are rapidly buying their way into the U.S. health care system, and as they do, new research finds they tend to increase costs and may also harm quality. A new BMJ systematic review rounded up 55 studies on the effects of private equity buyouts in health care globally to flesh out an overarching conclusion. The team of researchers found that private equity ownership generally means higher costs for patients, insurance companies, and government programs.
Fierce Healthcare
JULY 20, 2023
As the industry gears up for open enrollment to begin this fall, a new report offers a look into the major factors that could impact premium changes in the individual and small group markets. | As the industry gears up for open enrollment to begin this fall, a new report offers a look into the major factors that could impact premium changes in the individual and small group markets.
STAT
JULY 20, 2023
What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant.
Fierce Healthcare
JULY 20, 2023
The Office of Inspector General (OIG) is urging the feds and states to take on greater oversight of prior authorization denials in Medicaid managed care. | The Office of Inspector General is urging the feds and states to take on greater oversight of prior authorization denials in Medicaid managed care.
STAT
JULY 20, 2023
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Fierce Healthcare
JULY 20, 2023
The Centers for Medicare & Medicaid Services (CMS) has approved proposals from California and Kentucky for community-based mobile crisis intervention teams to provide Medicaid crisis services.< | Medicaid crisis service will be offered to residents in California and Kentucky under the federal American Rescue Plan, joining four other states.
pharmaphorum
JULY 20, 2023
Tornado-hit Pfizer facility could add to US drug shortages Phil.
Drug Store News
JULY 20, 2023
Walmart+ Assist is a program that offers customers on government assistance 50% off a monthly or annual Walmart+ paid membership plan.
Fierce Pharma
JULY 20, 2023
Despite the widespread hype surrounding new and powerful obesity medicines, the drugs are still out of reach for many Americans who could benefit. | Despite the widespread hype surrounding new and powerful obesity medicines, the drugs are still out of reach for many Americans who could benefit. A group of lawmakers is working to change that.
Fierce Healthcare
JULY 20, 2023
The healthcare challenges awaiting women who’ve given birth can sometimes be more problematic than those they faced during pregnancy and labor. | Recent and undocumented immigrants face barriers to postpartum care that could turn treatable conditions into serious health risks, according to a JAMA Network study.
pharmaphorum
JULY 20, 2023
UK project seeks saliva biomarker for rapid stroke diagnosis Phil.
Pharmacy Times
JULY 20, 2023
Despite the surge in new diabetes cases, the treatment options in in children remain limited.
Fierce Pharma
JULY 20, 2023
Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. | Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. Its latest move follows a separate $400 million pledge to build a plant in the country.
Let's personalize your content